Literature DB >> 6385606

The effect of prospective HLA-A and -B matching in 288 penetrating keratoplasties for herpes simplex keratitis.

H J Völker-Dieben, C C Kok-van Alphen, J D'Amaro, P de Lange.   

Abstract

A retrospective review of 288 penetrating keratoplasties (PKP) for herpes simplex keratitis demonstrated a 60.4% survival rate of clear grafts at 3 years. A highly significant difference in corneal graft survival in severely vascularized corneas (57.1% at 3 years) versus non- or slightly vascularized corneas (82.8% at 3 years) was observed (P = 0.009). Prospectively HLA-A and -B matched grafts in vascularized corneas revealed a significantly improved graft survival when compared to unmatched grafts (P = 0.035). Corneal graft survival in eyes grafted 'à chaud' was not significantly below the graft survival of vascularized corneas with a clinically non-active herpetic corneal disease. Recurrence of herpes simplex in the graft was observed in an earlier postoperative period in HLA-A and -B matched grafts (P = 0.0004).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6385606     DOI: 10.1111/j.1755-3768.1984.tb03962.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  4 in total

1.  Clear graft survival and immune reactions following emergency keratoplasty.

Authors:  P Maier; D Böhringer; T Reinhard
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-10-06       Impact factor: 3.117

2.  Recurrent herpetic keratitis in penetrating keratoplasty.

Authors:  C C Sterk; M J Jager; M Swart-vd Berg
Journal:  Doc Ophthalmol       Date:  1995       Impact factor: 2.379

3.  The effect of immunological and non-immunological factors on corneal graft survival. A single center study.

Authors:  H J Völker-Dieben
Journal:  Doc Ophthalmol       Date:  1984-04-16       Impact factor: 2.379

4.  Endothelial failure and rejection in recipients of corneas from the same donor.

Authors:  Lewis Downward; Mahmoud Ahmed; Cathy Hopkinson; Vito Romano; Elinor Curnow; Stephen B Kaye
Journal:  BMJ Open Ophthalmol       Date:  2022-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.